Boba & Biotech
Boba & Biotech is a candid podcast about what it takes to develop new drugs and the ecosystem of academics, biotechs, pharma and investors behind it. Our field is often misunderstood by outsiders and insiders alike due to the poor communication habits and complex science that underlie human disease.
I, Armon Sharei, was a PhD student in chemical engineering when I was first enamoured by the idea of engineering a patient’s own cells to attack their disease. Throughout my journey, we spun out a company, SQZ Biotech, from MIT, raised $400M in investor and partnered funding from Roche, and went public on the NYSE. Eventually my board and I had a big fight, I got kicked out and started all over again!
Please join me as we chat with the people that have dedicated their careers to improving human health and how they navigate the challenges of science, money, corporate politics and the rollercoaster of clinical development. As we sip on our boba throughout these episodes, I promise the only sugar coating will be on the bubbles!
Portal Biotechnologies, headquartered in Watertown, MA, is a rapidly scaling cell-engineering platform company redefining how scientists and clinicians engineer cells across research, drug discovery, and therapeutic applications. Since launching its first product in 2024, Portal has built a network of 100+ active customers, received an $8M contract from DARPA and been deployed in most of the top 10 global pharmaceutical companies and leading academic hospitals worldwide.
Armon Sharei, PhD, is the Founder and CEO of Portal Bio. Previously, Armon founded and served as CEO of SQZ Biotech (NYSE: SQZ), where he raised over $400M, advanced three oncology clinical trials, established a $1B+ collaboration with Roche, and led the IPO. A Stanford and MIT graduate and former Harvard Postdoctoral Fellow, Dr. Sharei holds 30+ patents and has been widely recognized for his scientific and entrepreneurial leadership.
© 2026 · more info
Artwork and data is from the podcast’s open RSS feed; we link directly to audio · Read our DMCA procedure
This podcast may use tracking and attribution and dynamic content insertion
Stats: Statistics are produced by Megaphone to help Boba & Biotech to understand how many downloads it is getting, or how many people are listening. Your device’s IP address and user agent is used to help calculate this figure. Megaphone is IAB v2 certified. Here is more detail about podcast statistics.
Tracking and attribution: Megaphone or its partners may connect the fact you listened to this podcast to an action elsewhere on the internet. For example - it may spot a device that downloaded an episode of Boba & Biotech later visited the website of an advertiser; or it may track that a device that listened to Boba & Biotech also listened to a different show. This form of attribution is used to measure advertising effectiveness.
Dynamic content insertion: Megaphone may use limited data that they know about you - the device you’re using, the approximate location you’re in, or other data that can be derived from this, like the current weather forecast for your area - to change parts of the audio. Boba & Biotech may do this for advertising or for other forms of content, like news stories.
Boba & Biotech is able to use the above tools since its podcast host or measurement company offers this service. It doesn’t mean that this individual podcast uses them, or has access to this functionality. We use open data.
Listen and follow
Information for podcasters
- Podcast GUID:
236ccc39-e96e-5ffa-971d-d553c7f8fb8d - The & character might make your podcast harder to search for - it’s a special character that needs careful encoding to always work in apps and websites, and it makes things complicated to request podcasts using voice assistants. How about using Megaphone’s dashboard to call it
Boba and Biotechinstead? - This podcast appears to be missing from Spotify, iVoox, and Luminary. We list all the podcast directories to be in.
- Validate this podcast’s RSS feed with Livewire, Truefans or CastFeedValidator